Apolipoprotein E (APOE), PARKIN and catechol-O-methyltransferase (COMT) genes and susceptibility to sporadic Parkinson's disease in Finland

Neuroscience Letters

Volumn 330, Issue 3, 2002, Pages 296-298

  Eerola, J ^a   Launes, J ^a   Hellstrom O ^b   Tienari, P J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b SEINÄJOKI CENTRAL HOSPITAL   (Finland)

Author keywords

Finland; Gene studies; Parkinson's disease

Indexed keywords

APOLIPOPROTEIN E; CATECHOL METHYLTRANSFERASE; METHIONINE; NUCLEOTIDE; PARKIN; VALINE;

ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXON; FEMALE; FINLAND; GENE FREQUENCY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; CATECHOL O-METHYLTRANSFERASE; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIGASES; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC; UBIQUITIN-PROTEIN LIGASES;

EID: 0037183750     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00819-4     Document Type: Article

References (21)

1. 123I-β-CIT in Clinical Practice? (Submitted)
2. Foltynie T., Brayne C., Barker R.A. The heterogeneity of idiopathic Parkinson's disease. J. Neurol. 249:2002;138-145.
3. Harhangi B.S., de Rijk M.C., van Duijn C.M., van Broeckhoven C., Hofman A., Breteler M.M. APOE and the risk of PD with or without dementia in a population-based study. Neurology. 54:2000;1272-1276.
4. Helisalmi S., Linnaranta K., Lehtovirta M., Mannermaa A., Heinonen O., Ryynänen M., Riekkinen P.Sr, Soininen H. Apolipoprotein E polymorphism in patients with different neurodegenerative disorders. Neurosci. Lett. 205:1996;61-65.
5. Hoda F., Nicholl D., Bennett P., Arranz M., Aitchison K.J., Al-Chalabi Kunugi H., Vallada H., Leigh P.N., Chaudhuri K.R., Collier D.A. No association between Parkinson's disease and low-activity alleles of catechol-O-methyltransferase. Biochem. Biophys. Res. Commun. 228:1996;780-784.
6. Kunugi H., Nanko S., Ueki A., Otsuka E., Hattori M., Hoda F., Vallada H., Arranz M.J., Collier D.A. High and low activity alleles of catechol-O-methyltransferase gene: ethnic difference and possible association with Parkinson's disease. Neurosci. Lett. 221:1997;202-204.
7. 18F-6-fluorodopa PET. J. Neurol. 247:2000;110-113.
8. Maraganore D.M., Farrer M.J., Hardy J.A., McDonnell S.K., Schaid D.J., Rocca W.A. Case-control study of debrisoquine-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease. Mov. Disord. 15:2000;714-719.
9. Mattila P.M., Koskela T., Roytta M., Lehtimäki T., Pirttilä T.A., Ilveskoski E., Karhunen P., Rinne J.O. Apolipoprotein E ε4 allele frequency is increased in Parkinson's disease only with co-existing Alzheimer pathology. Acta Neuropathol. 96:1998;417-420.
10. Moilanen J.S., Autere J.M., Myllylä V.V., Majamaa K. Complex segregation analysis of Parkinson's disease in the Finnish population. Hum. Genet. 108:2001;184-189.
11. Oliveri R.L., Zappia M., Annesi G., Bosco D., Annesi F., Spadafora P., Pasqua A.A., Tomaino C., Nicoletti G., Pirritano D., Labate A., Gambardella A., Logroscino G., Manobianca G., Epifanio A., Morgante L., Savettieri G., Quattrone A. The parkin gene is not involved in late-onset Parkinson's disease. Neurology. 57:2001;359-362.
12. Parsian A., Racette B., Goldsmith L.J., Perlmutter J.S. Parkinson's disease and apolipoprotein E: possible association with dementia but not with age at onset. Genomics. 79:2002;458-461.
13. Piccini P., Burn D.J., Ceravolo R., Maraganore D., Brooks D.J. The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann. Neurol. 45:1999;577-582.
14. Satoh J., Kuroda Y. Association of codon 167 Ser/Asn heterozygosity in the parkin gene with sporadic Parkinson's disease. NeuroReport. 10:1999;2735-2739.
15. Schiele F., De Bacquer D., Vincent-Viry M., Beisiegel U., Ehnholm C., Evans A., Kafatos A., Martins M.C., Sans S., Sass C., Visvikis S., De Backer G., Siest G. Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis. 152:2000;475-488.
16. Smith J.D. Apolipoprotein E4: an allele associated with many diseases. Ann. Med. 32:2000;118-127.
17. Sveinbjornsdottir S., Hicks A.A., Jonsson T., Petursson H., Gugmundsson G., Frigge M.L., Kong A., Gulcher J.R., Stefansson K. Familial aggregation of Parkinson's disease in Iceland. N. Engl. J. Med. 343:2000;1765-1770.
18. Tang, G., Xie, H., Xu, L., Hao, Y., Lin, D., Ren, D., Genetic study of Apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease, Am. J. Med. Genet., 114 (2002) 446-449.
19. Wakabayashi K., Kakita A., Hayashi S., Okuizumi K., Onodera O., Tanaka H., Ishikawa A., Tsuji S., Takahashi H. Apolipoprotein E ε4allele and progression of cortical Lewy body pathology in Parkinson's disease. Acta Neuropathol. 95:1998;450-454.
20. Wang M., Hattori N., Matsumine H., Kobayashi T., Yoshino H., Morioka A., Kitada T., Asakawa S., Minoshima S., Shimizu N., Mizuno Y. Polymorphism in the parkin gene in sporadic Parkinson's disease. Ann. Neurol. 45:1999;655-658.
21. Xie T., Ho S.L., Li L.S.W., Ma O.C.K. G/A 1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease. Mov. Disord. 12:1997;426-427.